Evidence map›Paper›PMID 19454252›Full record

ArticleAnalytical biochemistry2009

Recombination between linear double-stranded DNA substrates in vivo.

Kumaran Narayanan, Edmund Ui-Hang Sim, Nikolai V Ravin, Choon-Weng Lee

Abstract read
In one paragraph

Article in Analytical biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kumaran NarayananDepartment of Genetics and Genomic Sciences, Box 1498, Mount Sinai School of Medicine, 1425 Madison Avenue, EB 14-02, New York, NY 10029, USA. kumaran.narayanan@mssm.edu
Edmund Ui-Hang Sim
Nikolai V Ravin
Choon-Weng Lee

Funding

E coli-based vectors for BAC delivery to mammalian cellsR01DK069705 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI WARBURTON, PETER E · 2005 to 2008
$1.2M
NIDDK NIH HHS R01 DK069705
6 · The paper itself

Abstract

Recombineering technology in Escherichia coli enables targeting of linear donor DNA to circular recipient DNA using short shared homology sequences. In this work, we demonstrate that recombineering is also able to support recombination between a pair of linear DNA substrates (linear/linear recombineering) in vivo in E. coli. Linear DNA up to 100 kb is accurately modified and remains intact without undergoing rearrangements after recombination. This system will be valuable for direct in vivo manipulation of large linear DNA including the N15 and PY54 prophages and linear animal viruses, and for assembly of linear constructs as artificial chromosome vectors.

Indexed as

Recombination, GeneticDNADNA, BacterialEscherichia coliGenetic EngineeringDNADNA, Bacterial

Identifiers

PMID19454252
PMCPMC2784165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.